Comprehensive Study Notes on Respiratory Pharmacology: Histamine, Antihistamines, and Clinical Nursing Considerations
Histamine Pathophysiology and Allergic Reactions
Histamine Function and Mast Cell Release:
- Histamine serves as a major inflammatory mediator in numerous allergic disorders.
- Released directly from mast cells during immune-mediated allergic reactions.
- Exerts potent physiological effects on the vascular system and secretory glands by dilating blood vessels, increasing vascular permeability, and stimulating secretions.
Allergic Disorders Mediated by Histamine:
- Allergic rhinitis
- Anaphylaxis
- Angioedema
- Drug fevers
- Insect bite reactions
- Urticana (urticaria)
Pathophysiological Mechanisms of Anaphylaxis:
- Defined as a severe, life-threatening systemic allergic reaction triggered by the rapid release of excessive amounts of histamine.
- Smooth Muscle Constriction: Causes acute constriction of smooth muscle tissue, particularly in the lungs (bronchoconstriction) and the stomach.
- Secretory Hyperactivity: Drives a marked increase in body secretions across organ systems.
- Vascular Collapse: Causes severe systemic vasodilation combined with increased capillary permeability.
- Fluid Extravasation: Increased permeability results in the rapid movement of fluid out of the blood vessels and into the interstitial tissues.
- Hemodynamic and Tissue Consequences: Leads directly to a profound drop in blood pressure (BP) (hypotension) and extensive, widespread edema.
Histamine Receptor Blockers and Classification
Receptor Antagonists ( Blockers):
- Indicated primarily for inflammatory, allergic, and respiratory symptoms.
- Fexofenadine (trade name: Allegraj / Allegra)
- Loratadine (trade name: Claritin)
- Cetirizine (trade name: Reactine)
- Diphenhydramine (trade name: Benadryl)
Receptor Antagonists ( Blockers):
- Clinical role centers on gastric acid reduction in peptic ulcer disease.
- Cimetidine
- Ranitidine (trade name: zantac)
- Famotidine (trade name: Pepcid AC)
- Nizatidine (trade name: Axid)
Mechanisms of Action and Physiological Effects
Antihistamine Mechanism of Action (MOA):
- Competitively block the physiological action of histamine at target receptor sites.
- The binding of receptor blockers to histamine receptors prevents the adverse consequences normally induced by histamine stimulation.
- By occupying histamine receptors prior to histamine attachment, these agents prevent endogenous histamine from precipitating acute allergic responses.
Comparison of Histamine Stimulation vs. Antihistamine Intervention:
- Vascular Effects:
- Histamine: Promotes profound vasodilation and significantly increases capillary permeability, driving fluid shift and edema.
- Antihistamines: Bind to histamine receptors to counteract histamine stimulation, modulating vascular reactivity and reducing hyperpermeability.
- Secretory Effects:
- Histamine: Powerfully stimulates secretions across multiple organ networks, including the gastrointestinal (GI) tract, respiratory tract, salivary glands, and lacrimal glands.
- Antihistamines: Significantly reduce excessive bodily secretions across salivary, lacrimal, gastrointestinal, and respiratory tissues.
Indications and Clinical Applications
- Core Therapeutic Indications:
- Allergies: Relief of systemic and local hypersensitivity reactions, allergic rhinitis, and histamine-mediated dermatologic responses.
- Motion Sickness: Prevention and treatment of nausea and equilibrium disturbances associated with motion.
- Parkinson's Disease: Used as an adjunct intervention in managing specific motor and neurological manifestations.
- Vertigo: Alleviation of vestibular imbalance and spinning sensations.
- Sleep Disorders: Used for sedative properties to treat insomnia and facilitate sleep onset.
- Common Cold: Administered to relieve cold symptoms, such as rhinorrhea and hypersecretion.
Clinical Contraindications and Precautions
- Conditions Warranting Strict Contraindication or Cautious Administration (*Use w/ caution):
- Acute Angle Glaucoma: Risk of anticholinergic-induced pupillary dilation and increased intraocular pressure.
- Cardiac Disease / Hypertension (HTN): Risk of hemodynamic instability, tachycardia, or exacerbated hypertension.
- Kidney Disease: Altered renal clearance leading to drug accumulation and heightened toxicity.
- Bronchial Asthma / COPD: Drying of secretions and potential worsening of airway compromise.
- Peptic Ulcer Disease: Requires caution, particularly when balancing histamine-receptor dynamics.
- Seizure Disorders: Lowered seizure threshold associated with certain central antihistaminergic agents.
- Benign Prostatic Hyperplasia (BPH): Anticholinergic urinary retention risks exacerbating bladder outlet obstruction.
- Pregnancy: Potential teratogenic or perinatal risks warranting careful risk-benefit evaluation.
Adverse Effects and Nonsedating Formulations
Spectrum of Adverse Effects:
- Anticholinergic Side Effects:
- Dry mouth (xerostomia)
- Difficulty urinating (urinary retention / hesitation)
- Constipation
- Vision changes (such as blurred vision secondary to pupillary changes)
- Central Nervous System Depressant Effects:
- Significant drowsiness!
- Can induce a sedative continuum ranging from mild drowsiness to deep sleep.
Nonsedating Antihistamines:
- Pharmacodynamics: Work peripherally to selectively block the actions of histamine, preventing major penetration across the blood-brain barrier.
- Tolerability Advantage: Cause significantly fewer central nervous system (CNS) side effects (markedly reduced sedation and cognitive slowing).
- Pharmacokinetics: Feature a longer duration of action compared to older first-generation agents, supporting once-daily or less frequent dosing regimens.
- Specific Nonsedating Agents:
- Loratadine
- Cetirizine
- Fexofenadine
Critical Warnings for Acute Respiratory Emergencies
Lower Respiratory Disease Precautions:
- Use extreme caution and observe specific restrictions in the presence of lower respiratory diseases, such as pneumonia.
Absolute Restriction in Acute Asthmatic Attacks:
- Antihistamines are strictly contraindicated as the sole drug therapy during acute asthmatic attacks.
- Antihistamines do not produce rapid, direct bronchodilation required to resolve acute airway obstruction and bronchospasm.
Emergency Rescue Pharmacotherapy:
- Acute bronchospasm and severe anaphylactic attacks require immediate emergency bronchodilators and adrenergic agonists:
- Salbutamol (Lysalbutamol)
- Epinephrine (Lepinephnhe)
Patient Education and Nursing Care
Monitoring and Immediate Reporting:
- Educate the patient to monitor for and immediately report excessive sedation, acute confusion, or signs of hypotension (abnormal drop in blood pressure).
Safety and Activity Restrictions:
- Instruct the patient to avoid driving (cirining), operating machinery, consuming alcohol, or ingesting concurrent CNS depressants due to compounding sedative and psychomotor impairment.
Drug Interactions and Physician Consultation:
- Advise patients never to combine antihistamines with other medications without first checking with a doctor.
Administration Technique:
- Instruct patients to take medication with food to prevent gastrointestinal upset.
Management Strategies for Dry Mouth:
- Perform diligent, regular mouth care.
- Chew gum to stimulate salivary flow.
- Suck on hard candy to alleviate xerostomia.